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The Journal of Immunology
TCR Affinity for In Vivo Peptide-Induced Thymic Positive
Selection Fine-Tunes TCR Responsiveness of Peripheral
CD8+ T Cells
Umme Shahina Khanom,*,1 Izumi Ohigashi,*,1 Sayumi Fujimori,* Kenta Kondo,†
Kensuke Takada,*,2 and Yousuke Takahama†
The affinity for TCR interactions with self-peptide/MHC complexes (pMHC) in the thymus critically affects immature thymocytes
that newly express TCRs. Previous fetal thymus organ culture experiments have indicated that difference in the affinity for thymic
TCR/pMHC interactions not only determines thymocyte fate between positive and negative selection, but also affects Ag respon-
siveness of positively selected thymocytes. In the current study, we examined whether TCR/pMHC affinity during positive
selection in the thymus would further affect Ag responsiveness of mature T cells in the periphery. To do so, OVA peptide variants
were in vivo administered to TAP1-deficient OT-I/TCR-transgenic mice in which T cell development was otherwise arrested at
CD4+CD8+ thymocytes because of the lack of self-pMHC presentation in thymic APCs. We found that a group of peptide variants
induced the transient generation of OT-I CD8+ T cells in the thymus and the periphery. We also noticed that the affinity threshold
for positive and negative selection detected in adult mice in vivo was higher than that measured in fetal thymus organ culture
experiments in vitro. Interestingly, we further found that the affinity for positively selecting peptides proportionally affected TCR
responsiveness of peripheral naive CD8+ T cells. These results indicate that in vivo administration of a peptide can promote T cell
selection in the thymus and the affinity for TCR/pMHC interaction during positive selection fine-tunes Ag responsiveness of
peripheral T cells. The Journal of Immunology, 2019, 203: 881–887.
S
elf-antigen recognition in the thymus determines the fate
of newly generated T cells. The interaction between TCR
expressed by developing thymocytes and self-peptide/MHC
complexes (pMHC) displayed in the thymus critically affects the
developmental outcome of thymocytes, determining their survival
or absence (i.e., positive and negative selection) and their lineage
direction to become functionally different cells (e.g., CD4 helper
and CD8 killer). Studies using fetal thymus organ culture of TCR-
transgenic thymocytes have indicated that a low-affinity interac-
tion between TCR and pMHC promotes thymocyte maturation to
give rise to functionally competent T cells (i.e., positive selec-
tion), whereas a high-affinity interaction causes the absence of
self-reactive T cells (i.e., negative selection) (1–3). A narrow
range of the TCR/pMHC affinity sets the threshold for positive
and negative selection of developing thymocytes, contributing to
the enrichment of functionally potent and self-protective T cells
while excluding potentially harmful self-reactive T cells from a
mature T cell pool (4, 5).
Recent experiments have indicated that TCR/pMHC affinity
during positive selection in the thymus further affects TCR re-
sponsiveness of mature thymocytes. Within the window of the
affinity for positively selecting TCR/pMHC interaction, a relatively
high-affinity–mediated positive selection promotes the generation
of mature thymocytes that express a large amount of cell-surface
CD5 and that exhibit high TCR responsiveness, compared with
mature thymocytes generated by a low-affinity–mediated positive
selection (6). Fetal thymus organ culture experiments have dem-
onstrated a direct link between TCR/pMHC affinity during posi-
tive selection and TCR responsiveness of mature thymocytes (6).
A further link with peripheral T cell function was indirectly
suggested by the amount of cell-surface CD5 molecules (7–9),
which is strongly affected by TCR signals during and after thymic
positive selection (10). Indeed, TCR signals that influence CD5
expression levels in T cells are not limited during positive selec-
tion in the thymus, but are widely distributed during subsequent
T cell development, homeostasis, and immune response (7–10).
Whether or not TCR/pMHC affinity during positive selection in
the thymus remains influential to CD5 expression levels and TCR
responsiveness of mature T cells in the periphery has not been
addressed.
In the current study, we examined the effect of in vivo admin-
istration of various OVA antigenic peptide (OVAp) variants in
OVA-Ag–specific, OT-I/TCR-transgenic, TAP1-deficient mice in
which T cell development was otherwise arrested at CD4+CD8+
thymocytes because of the lack of positive-selection–inducing
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self-pMHC presentation in the thymus (11, 12). Our results show
the following: 1) the injection of a group of peptide variants in-
duced the generation of a cohort of OT-I CD8+ T cells in the
thymus and the periphery, 2) the affinity threshold for positive and
negative selection by the peptide injection experiments in adult
mice in vivo was higher than that previously measured in fetal
thymus organ culture experiments in vitro, and 3) the affinity for
positively selecting peptides proportionally affected Ag respon-
siveness of CD8+ T cells in the periphery. Thus, our results in-
dicate that the in vivo administration of a peptide can modulate
Ag-specific T cell repertoire selection in the thymus and that the
affinity for TCR/pMHC interaction during positive selection in-
fluences TCR responsiveness of mature T cells in the periphery.
Materials and Methods
Mice
TAP1-deficient, OT-I/TCR-transgenic mice (4, 11) were maintained under
specific pathogen-free conditions in the Institute of Advanced Medical
Sciences at the University of Tokushima. All animal experiments were
performed with approval from the Animal Experimentation Committee at
the University of Tokushima.
In vivo peptide administration
OVA aa 257–264 peptide SIINFEKL (OVAp) and its variants EIINFEKL
(E1), SIIQFEHL (Q4H7), SIITFEKL (T4), SIIQFERL (Q4R7), and SIIQFEKL
(Q4) as well as vesicular stomatitis virus 8 (VSV8) aa 52–59 peptide
RGYVYQGL were purchased from GenScript. TAP1-deficient, OT-I/
TCR-transgenic mice at 4 wk old were i.p. injected with 25–100 mg of
peptide in 100 ml of PBS. Mice were analyzed on the indicated day after the
peptide administration.
Fetal thymus organ culture
Fetal thymus lobes isolated from TAP1-deficient, OT-I/TCR-transgenic
mice on embryonic day 15.5 were organ cultured for 4 d as described
(13). Indicated peptides were included in the culture at 20 mM. Cells were
analyzed by multicolor flow cytometry.
Thymus section analysis
Coronal sections of frozen thymus at 10-mm thickness were stained for
H&E. Microscopic images were analyzed for cortical and medullary re-
gions using Adobe Photoshop, as previously described (14, 15).
Flow cytometry and cell sorting
Single-cell suspensions isolated from indicated mouse organs were stained
on ice with Abs specific for CD4 (RM4-5; eBioscience), CD5 (53-7.3;
eBioscience), CD8a (53-6.7; eBioscience), CD8b (YTS 156.7.7; Absolute
Ab), CD25 (3C7; BioLegend), CD44 (IM7; eBioscience), CD62L (MEL-
14; BioLegend), CD69 (HI.2F3; BioLegend), CD122 (5H4; BioLegend),
CD132 (TUGm2; BioLegend), and Va2 (B20.1; BioLegend). For the
staining with Ab specific for CCR7 (4B12; eBioscience), cells were in-
cubated at 37˚C for 30 min before the staining with other Abs. To isolate
naive CD8+ T cells, spleen cells were stained with biotinylated Abs spe-
cific for CD4, CD44, and B220 (RA3-6B2; BioLegend), and cells that did
not bind to the Abs were enriched with magnetic bead–conjugated strep-
tavidin (Miltenyi Biotec). Multicolor flow cytometry and cell sorting were
performed on FACSVerse and FACSAria II (BD Biosciences), respectively.
T cell stimulation
Cells were placed in culture wells precoated with anti-CD3εAb (145-2C11;
eBioscience) at the indicated concentrations and 10 mg/ml of anti-CD28
Ab (37.51; eBioscience). Where indicated, cells were cultured with OVAp-
Kb peptide MHC tetramers (MBL) at the indicated dilutions. Cells were
stimulated at 37˚C for 3 h and CD69 expression was measured by flow
cytometry.
Statistical analysis
Statistical significance was evaluated using the two-tailed unpaired Student
t test. All p values ,0.05 were considered statistically significant.
Results
Effects of OVA peptide variants in TAP1-deficient,
OT-I/TCR-transgenic fetal thymus organ cultures
To examine the effects of antigenic peptide variants in vivo, we first
verified the effects of those peptides in TAP1-deficient, OT-I/TCR-
transgenic fetal thymus organ cultures in vitro. It was previ-
ously reported that OVA peptide variants could promote positive
and negative selection in b2m-deficient, OT-I/TCR-transgenic
fetal thymus organ cultures (1, 4). In b2m-deficient, OT-I/TCR-
transgenic mice, b2m deficiency causes the lack of cell-surface
MHC class I molecules and, thereby, the loss of positive selection
for the generation of CD8+ T cells, which is dependent on TCR
recognition of self-pMHC class I complexes in the thymus (1, 4).
The addition of OVA peptide variants in the fetal thymus organ
cultures identified that E1 and Q4H7 peptides, which exhibit low
affinity for OT-I/TCR along with MHC class I molecule Kb,
promote positive selection for the generation of CD42CD8+ thy-
mocytes, whereas high-affinity peptides, Q4R7 and Q4, as well as
the original OVAp, induce negative selection to delete or devel-
opmentally deviate immature thymocytes (4). The intermediate-
affinity peptide T4 exhibited the threshold between positive and
negative selection (4).
Similarly, we detected the arrest of thymocyte development at
the CD4+CD8+ stage in TAP1-deficient, OT-I/TCR-transgenic
fetal thymus organ cultures (Fig. 1A) in which the lack of pep-
tide transporter TAP1 causes the defective expression of self-
pMHC class I complexes on the cell surface and the defective
FIGURE 1. E15.5 fetal thymus of TAP1-deficient,
OT-I/TCR-transgenic mice was cultured in the pres-
ence or absence of indicated peptides (20 mM). VSV8
peptide with an irrelevant specificity was used as
control. (A) Representative CD4 and CD8b profiles of
PI2 viable thymocytes are shown. Numbers indicate
the frequencies of cells in the quadrants. (B) Numbers
(means 6 SEs; n = 3) of total, CD4+CD8+, and
TCRhigh CD42CD8+ thymocytes are plotted. Statisti-
cally significant increase in cell number is highlighted
by red asterisks. *p, 0.05, **p, 0.01, ***p, 0.001.
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positive selection for the generation of CD8+ T cells (11, 12). In
agreement with previous reports, only the low-affinity peptides,
E1 and Q4H7, with the affinity below the reported threshold be-
tween positive and negative selection, promoted the appearance of
CD42CD8+ thymocytes in TAP1-deficient, OT-I/TCR-transgenic
fetal thymus organ cultures (Fig. 1A, 1B).
These results agreed with previous results and verified the effects
of graded-affinity OVA peptide variants on thymocyte development
in TAP1-deficient, OT-I/TCR-transgenic mice in fetal thymus or-
gan culture experiments.
In vivo administration of OVA peptide variants in
TAP1-deficient, OT-I/TCR-transgenic mice generates a
cohort of CD42CD8+ mature thymocytes
We then examined the effects of antigenic peptide variants in vivo
by i.p. injecting various OVA peptide variants into TAP1-deficient,
OT-I/TCR-transgenic adult mice in which thymic positive selection
for generating CD8+ T cells is arrested (Fig. 2A). We noticed that
the administration of high-affinity peptides Q4 and OVAp caused
the loss of CD4+CD8+ thymocytes rapidly by day 2 (Fig. 2A), in
agreement with the negative selection of CD4+CD8+ thymo-
cytes in fetal thymus organ culture (Fig. 1). Unlike fetal thymus
organ culture, however, we failed to detect a clear generation of
CD42CD8+ thymocytes by the administration of low-affinity
peptide E1. Instead, we noticed that the previously reported
intermediate-affinity threshold peptides, T4 and Q4R7, elevated
the frequency of CD42CD8+ thymocytes on day 4. The increase in
the frequency of CD42CD8+ thymocytes reflected the increase
in the absolute number of mature TCR-Va2high CD42CD8+ thy-
mocytes (Fig. 2B), whereas those TCRhigh CD42CD8+ thymo-
cytes did not contain CD25high proliferating cells (Fig. 3A),
indicating that T4 and Q4R7 promoted the de novo generation of
OT-I/TCRhigh CD8+ T cells rather than induced the outgrowth of
a small number of pre-existing TCRhigh CD42CD8+ mature thy-
mocytes or caused the accumulation of TCRlow CD42CD8+
immature precursor cells. We also noted that T4 and Q4R7 en-
larged the size of the thymic medullary region on day 4, further
supporting that T4 and Q4R7 promoted the thymic generation of
OT-I/TCRhigh CD8+ mature thymocytes (Fig. 3B). In addition to
T4 and Q4R7, the low-affinity peptide Q4H7 also promoted the
generation of mature TCR-Va2high CD42CD8+ thymocytes, albeit
at a low cellularity (Fig. 2A, 2B). The peptide-induced generation
of TCRhigh CD42CD8+ thymocytes was apparent on day 4 and
day 5 after the peptide administration and disappeared on day 7 or
later (Fig. 2A, 2B), indicating that the peptide-induced positive
selection was transient. The decrease in CD4+CD8+ thymocytes
by the high-affinity peptides was also transient, and the cell
number recovered to normalcy by day 7 (Fig. 2A, 2B). We also
noted that the 2-fold increase or decrease in the dosage of injected
peptides did not markedly alter the effects onto TAP1-deficient,
OT-I/TCR-transgenic CD4+CD8+ and CD42CD8+ thymocytes on
day 4 (Fig. 3C).
These results indicate that the in vivo administration of antigenic
peptide variants promotes the transient generation of a cohort of
TCRhigh CD42CD8+ mature thymocytes. The affinity threshold
for positive and negative selection in vivo appears different from
and higher than that detected in vitro.
In vivo administration of OVA peptide variants in
TAP1-deficient, OT-I/TCR-transgenic mice generates a
cohort of CD8+ T cells in the periphery
We next examined whether the peptide-mediated positive selection
in the thymus in vivo would lead to the generation of T cells in the
periphery. To do so, we analyzed spleen cells in TAP1-deficient,
OT-I/TCR-transgenic mice that were injected with OVA peptide
variants (Figs. 4, 5), and found that T4 and Q4R7 promoted a
significant (p , 0.05) increase in the cellularity of TCR-Va2+
CD8+ OT-I/TCR-transgenic CD44lowCD62Lhigh naive T cells on
day 9 (Figs. 4, 5A, 5B). The increase was transient, as the sig-
nificant increase in the number of OT-I/TCR-transgenic naive
FIGURE 2. Indicated peptides were i.p. administered to TAP1-deficient, OT-I/TCR-transgenic mice at 4 wk old. (A) Representative CD4 and CD8
profiles of PI2 viable thymocytes on indicated days after the administration of 50 mg of peptides are shown. Numbers indicate frequencies of cells in
quadrants. (B) Numbers (means 6 SEs; n = 5–6) of total, CD4+CD8+, and TCRhigh CD42CD8+ thymocytes are plotted. Statistically significant increase in
cell number is highlighted by red asterisks. *p , 0.05, **p , 0.01, ***p , 0.001.
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T cells was detectable on day 9, but not day 4 or day 12 (Fig. 5A,
5B). The transiency was presumably due to the lack of self-pMHC
required for the survival of newly generated T cells in TAP1-
deficient mice. Meanwhile, the significant increase in the num-
ber of OT-I/TCR-transgenic naive T cells was systemic, as OT-I/
TCR-transgenic naive T cells on day 9 was detectable not only in
the spleen, but also in the lymph nodes (Fig. 5B, 5C). The in-
creased OT-I/TCR-transgenic CD44lowCD62Lhigh CD8+ T cells
on day 9 were CD25 (IL-2Ra)low CD122 (IL-2Rb)low CD132
(IL-2Rg)low (Fig. 5D), indicating that T4 and Q4R7 promoted the
de novo generation of OT-I/TCR-transgenic naive CD8+ T cells
rather than the outgrowth of a small number of preexisting CD8+
T cells in the spleen.
These results indicate that the in vivo administration of antigenic
peptide variants promotes the transient generation of naive CD8+
T cells in the periphery, subsequent to the transient generation of
TCRhigh CD42CD8+ mature thymocytes in the thymus. The
generation of peripheral CD8+ naive T cells was dependent on the
affinity of injected peptides. Similar to the generation of TCRhigh
CD42CD8+ mature thymocytes, the affinity required for the
generation of peripheral T cells was higher in in vivo peptide
injection experiments than in in vitro fetal thymus organ culture
experiments.
TCR affinity for thymic selection affects CD5 expression levels
in peripheral T cells
We also wanted to examine whether TCR affinity among the
peptide ligands that promote positive selection in vivo would affect
the phenotype of positively selected T cells in the thymus and the
periphery. It was shown that the ligand affinity for TCR engage-
ment during positive selection at CD4+CD8+ thymocytes is pro-
portionally correlated with the expression level of cell-surface
CD5 in TCR-stimulated thymocytes, including positively selected
CD4/CD8 single-positive thymocytes (10). However, it was un-
clear how TCR-ligand affinity during positive selection at
CD4+CD8+ thymocytes would persistently affect CD5 expression
level in T cells beyond the export from the thymus to the pe-
riphery. As shown in Fig. 5, CD5 expression levels in positively
selected TCRhigh CD42CD8+ thymocytes detected on day 4 and in
TCRhigh CD42CD8+ CD44lowCD62Lhigh spleen naive T cells
detected on day 9 were proportionally correlated with OT-I/TCR
affinity of the injected peptide variants between Q4H7 and T4
(Fig. 6A, 6B). In contrast, the proportional correlation was less
clear and not statistically significant in positively selected thy-
mocytes and spleen naive T cells between T4-injected mice and
Q4R7-injected mice (Fig. 6A, 6B), even though the affinity for
OT-I/TCR is different between these two peptides (T4 , Q4R7).
Unlike CD5 expression levels, the expression levels of TCR and
CD8 in TCRhigh CD42CD8+ CD44lowCD62Lhigh spleen naive
T cells on day 9 were not significantly different between T4-
injected mice and Q4R7-injected mice (Fig. 7).
These results indicate that cell-surface CD5 expression levels in
positively selected CD42CD8+ thymocytes and even in peripheral
CD42CD8+ naive T cells are proportionally correlated with TCR
ligand affinity for positive selection when Q4H7 and T4 peptides
are compared, although the proportional correlation between TCR
FIGURE 4. Indicated peptides (50 mg) were i.p. administered to TAP1-deficient, OT-I/TCR-transgenic mice at 4 wk old. Spleen cells were analyzed on
indicated days after the administration of peptides. Representative CD44 and CD62L profiles of CD8+Va2high cells are shown. Numbers in quadrants
indicate frequencies of cells in boxes. Numbers at the bottom indicate absolute numbers per mouse of CD44lowCD62Lhigh CD8+Va2high cells (shown in red
boxes).
FIGURE 3. Indicated peptides were i.p. adminis-
tered in TAP1-deficient, OT-I/TCR-transgenic mice at
4 wk old. (A) CD25 expression in TCRhigh CD42CD8+
thymocytes on day 4. Numbers indicate frequencies of
cells in boxes. (B) Thymic sections were stained for
H&E. Areas of the medullary regions normalized to
areas of the cortical regions (means 6 SEs; n = 4–5)
are plotted. (C) Representative CD4 and CD8 profiles
of PI2 viable thymocytes on day 4 after administration
of indicated concentrations of peptides are shown.
Numbers indicate frequencies of cells in quadrants.
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ligand affinity for thymic positive selection and CD5 expression
level in T cells is not always clear and insignificant at the affinity
between T4 and Q4R7 peptides.
TCR affinity for positive selection affects Ag responsiveness of
peripheral T cells
We finally examined whether TCR ligand affinity during peptide-
induced positive selection in vivowould affect TCR responsiveness
of positively selected T cells. We found that CD69 upregulation
response to TCR stimulation with anti-CD3 plus anti-CD28 Abs in
positively selected TCRhighCD42CD8+ thymocytes was propor-
tionally correlated with TCR affinity among Q4H7, T4, and Q4R7
peptide variants injected for inducing positive selection (Fig. 8A).
CD69 response to OVAp-Kb tetramer was similarly influenced by
TCR affinity for positive-selection–inducing peptide variants, even
though the difference in CD69 upregulation was more pronounced
between Q4H7 and T4 peptides and less pronounced between T4
and Q4R7 peptides (Fig. 8B). TCR affinity for the injected peptide
variants further affected TCR-stimulated CD69 responses in
CD42CD8+ CD44lowCD62Lhigh naive spleen T cells in a similarly
proportional manner (Fig. 8C, 8D). However, TCR responsiveness
of CD42CD8+ CD44lowCD62Lhigh naive spleen T cells was not
significantly different among the different time points between
day 4 and day 12 after the peptide administration (Fig. 8E, 8F),
despite that the peptide-promoted T cell generation was transient
and maximum on day 9 after peptide injection (Fig. 5A, 5B).
These results indicate that TCR responsiveness of positively se-
lected CD42CD8+ thymocytes, and peripheral CD42CD8+ naive
T cells is proportionally correlated with TCR affinity for in vivo
injected positive-selection–inducing peptides.
Discussion
The results obtained in this study demonstrate that the in vivo
administration of OVA peptide variants T4 and Q4R7 induces
the generation of OT-I CD8+ T cells in the thymus and the pe-
riphery. The peptide-induced generation of CD8+ T cells was
transient, as the thymic cohort was optimally detected 4 d after the
peptide administration and the cohort in the secondary lymphoid
organs, including the spleen and the lymph nodes, was optimally
detected 9 d after the administration. The generated CD8+ T cells
were phenotypically normal, without overexpression of IL-2 re-
ceptor chains, reflecting the consequence of de novo positive se-
lection in the thymus rather than the outgrowth of a small number
of preexisting T cells or the accumulation of aberrant T cells. It
was previously shown that the keratin 14 promoter–driven trans-
genic expression of another low-affinity peptide variant E1 in
TAP1-deficient, OT-I/TCR-transgenic mice restored the genera-
tion of OT-I CD8+ T cells in the thymus and the spleen (16). The
keratin 14 promoter drives transgene expression in epithelial cells,
including cortical thymic epithelial cells (16, 17), suggesting that
E1-mediated positive selection in the thymic cortex is responsible
for the restoration of OT-I CD8+ T cells in vivo. These results
together indicate that the in vivo delivery of a peptide could in-
duce positive selection of T cells that interact with the pMHC at a
low affinity in the thymus.
The in vivo administration of peptides offers promise as therapy for
various human diseases, including cancer and diabetes (18, 19).
Peptides are also included in nutritional supplements and functional
diets (20, 21). Our results indicate that peptide administration in vivo
can affect thymocyte development, including the alteration of the
T cell repertoire by the positive selection of T cells that interact with
the pMHC in the thymus at a low affinity. Careful consideration of
possible peptide delivery into the thymus and the subsequent alter-
ation of thymocyte selection and T cell development may help
avoiding the adverse effects of peptide administration in humans.
Our results show that the affinity threshold for positive and
negative selection in in vivo peptide injection experiments is
different from and higher than that measured in fetal thymus organ
culture experiments in vitro. Previous fetal thymus organ culture
experiments have shown that a set of low-affinity peptides, in-
cluding E1 and Q4H7, promotes the positive selection of OT-I
CD8+ T cells, whereas a set of high-affinity peptides, including
Q4R7, Q4, and OVAp, causes the negative selection of OT-I/TCR-
expressing thymocytes (1, 4). It was also shown that the T4
FIGURE 5. Indicated peptides (50 mg) were i.p.
administered to TAP1-deficient, OT-I/TCR-trans-
genic mice at 4 wk old. (A) Spleen cells were
analyzed on indicated days after the administra-
tion of peptides. Representative CD8 and Va2
profiles of CD44lowCD62Lhigh cells are shown. Num-
bers indicate frequencies of cells in boxes. (B) Numbers
(means 6 SEs) of Va2+CD8+CD44lowCD62Lhigh naive
T cells in the spleen on day 4 (n = 4) and day 9 (n = 6)
are plotted. (C) Numbers (means 6 SEs; n = 4) of
Va2+CD8+CD44lowCD62Lhigh naive T cells in the
lymph nodes on day 9. Statistically significant in-
crease in cell number is highlighted by red asterisks.
*p , 0.05, ***p , 0.001. (D) CD25, CD122, and
CD132 expression in Va2+CD8+CD44lowCD62Lhigh
naive T cells in the spleen on day 9. Numbers indi-
cate frequencies of cells in boxes.
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peptide exhibits an affinity threshold between positive and nega-
tive selection for OT-I thymocytes (4). As shown in Fig. 1 in this
study, our results from fetal thymus organ culture experiments
agree with published results, including the affinity threshold for
OT-I thymocytes. In contrast, however, our results from in vivo
peptide injection experiments show that T4 and Q4R7 promoted
the positive selection of OT-I CD8+ T cells, whereas the injection
of Q4 and OVAp did not elevate the cellularity of OT-I CD8+
T cells in the thymus, indicating that the affinity threshold de-
tected from in vivo peptide injection experiments is higher than
that measured in fetal thymus organ culture experiments in vitro.
We speculate that the difference between the results of those
in vivo and in vitro experiments could be due to the difference in
the accessibility of the peptides to form the peptide MHC class I
complexes displayed by cortical thymic epithelial cells and,
thereby, the difference in the availability and the avidity of the
peptide MHC class I complexes to induce thymocyte positive
selection. Indeed, it was previously demonstrated that the different
availability of selecting peptides, including the T4 threshold
peptide used in this study, markedly affects the fate of developing
thymocytes (4, 5, 22). It has been also shown that peptides tend to
have short half-lives in vivo and, therefore, be low in bioavail-
ability for function (18, 19, 23), which may contribute to the
limited availability of selecting peptides in the thymus by in vivo
administration. It is interesting to note that peptide E1, which
induced positive selection in vivo by K14 promoter–mediated
transgenic expression in thymic epithelial cells (16), did not
promote positive selection in our peptide injection experiments.
This difference may also result from the difference in the abun-
dance and the avidity of E1-Kb complexes in the thymic cortex.
The transgenic expression in thymic epithelial cells may provide a
much higher abundance in the formation of E1-Kb complexes in
the thymic cortex than the i.p. peptide injection. Thus, the affinity
threshold between positive and negative selection shared by sev-
eral TCR-transgenic thymocytes (5) may be applicable only in
certain experimental conditions in which cortical thymic epithelial
cells are sufficiently saturated with positive-selection–inducing
pMHC, for example, by peptide addition in in vitro fetal thymus
organ culture experiments or transgenic expression of the peptide
in thymic epithelial cells. To clarify these issues, it would,
therefore, be interesting to measure the amount of actual selecting
pMHC in the thymus, particularly those expressed by cortical
thymic epithelial cells, for example, by using Abs or TCR tetra-
mers specific for those selecting pMHC (24, 25).
Most interestingly, our results demonstrate that TCR affinity for
positive-selection–inducing OVA peptide variants influences TCR
responsiveness of positively selected OT-I CD8+ T cells in the
thymus and the periphery. It was previously shown that TCR/pMHC
affinity during positive selection proportionally affects TCR re-
sponsiveness of mature thymocytes (6). However, it was not shown
that the affinity for positively selecting TCR/pMHC interaction
further affects TCR responsiveness of mature T cells in the pe-
riphery, even though the possibility was indirectly suggested by the
analysis of cell-surface CD5 expression levels in mature peripheral
T cells (7–9). In contrast, our results directly demonstrate that the
difference in TCR affinity among Q4H7, T4, and Q4R7 during
thymic positive selection proportionally programs the intrinsic dif-
ference in TCR responsiveness of positively selected OT-I CD8+
T cells in the spleen. These results may be relevant considering that
TCR-mediated positive selection in the thymus actually corresponds
to the primary response for newly generated T cells (26). The
quality of Ag receptor engagement during the primary response
(i.e., positive selection of newly generated T cells in the thymus)
may well affect the subsequent functional behavior of peripheral
T cells during immune responses.
The CD5 expression level in spleen naive OT-I CD8+ T cells was
also proportionally correlated with positive-selection–inducing TCR
FIGURE 7. Indicated peptides (50 mg) were i.p. administered to
TAP1-deficient, OT-I/TCR-transgenic mice at 4 wk old. Cell-surface
expression of TCRb and CD8a was analyzed on day 9 for
CD42CD8+CD44lowCD62LhighTCRhigh spleen cells. Relative median
fluorescence intensity (RFI) (means 6 SEs; n = 6) of TCRb and CD8a
expression normalized to the median fluorescence intensity in PBS-injected
group. p $ 0.05.
FIGURE 6. Indicated peptides (50 mg) were i.p. administered to TAP1-
deficient, OT-I/TCR-transgenic mice at 4 wk old. (A) CD5 expression was
analyzed on day 4 for CD42CD8+TCRhigh thymocytes and on day 9 for
CD42CD8+CD44lowCD62LhighTCRhigh spleen cells. Shaded histograms
indicate profiles with control IgG. Numbers indicate median fluorescent
intensities of CD5 histograms. (B) Relative median fluorescence intensity
(RFI) (means 6 SEs; n = 4–6) of CD5 expression normalized to the me-
dian fluorescence intensity in PBS-injected group. *p , 0.05, **p , 0.01,
***p , 0.001.
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ligand affinity between Q4H7 and T4, whereas the proportional
correlation was nonsignificant between T4 and Q4R7 for positive
selection in the thymus. These results indicate that the difference in
TCR affinity during positive selection does not always cause clear
difference in CD5 expression level in naive T cells in the periphery.
In conclusion, our results indicate that the in vivo administration
of a peptide can induce T cell positive selection in the thymus and
that the affinity for TCR/pMHC interaction during positive se-
lection in the thymus fine-tunes Ag responsiveness of mature
T cells in the periphery.
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FIGURE 8. Indicated peptides (50 mg)
were i.p. administered to TAP1-deficient,
OT-I/TCR-transgenic mice at 4 wk
old. TCRhigh CD42CD8+ thymocytes
obtained on day 4 (A and B) and
TCR+CD8+CD44lowCD62Lhigh spleen
naive T cells obtained on day 9 (C and
D) were stimulated with indicated con-
centrations of plate-bound anti-CD3
Ab in the presence of anti-CD28 Ab
(10 mg/ml) (A and C) or indicated
dilutions of OVAp-Kb peptide/MHC
tetramers (B and D) for 3 h. (E and F)
TCR+CD8+CD44lowCD62Lhigh spleen
naive T cells from indicated days after
the administration of Q4R7 (E) or T4 (F)
peptide were stimulated with indicated
concentrations of plate-bound anti-CD3
Ab in the presence of anti-CD28 Ab
(10 mg/ml). Plotted are frequencies of
CD69-expressing cells (means 6 SEs;
n = 3–5). *p , 0.05, **p , 0.01.
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